HYCAMTIN Side Effects

6923687-8 | Anaemia, Dermatitis Bullous, Leukopenia, Pancytopenia, Skin Exfoliation, Thrombocytopenia, Toxic Skin Eruption
on Aug 02, 2010 Male patient from SPAIN , 49 years of age, was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dermatitis bullous, leukopenia, pancytopenia, skin exfoliation, thrombocytopenia, toxic skin eruption. Hycamtin dosage: 1mgm2 Per Day. Patient was hospitalized.

6917123-5 | Anaemia, Dermatitis Bullous, Leukopenia, Pancytopenia, Skin Exfoliation, Thrombocytopenia, Toxic Skin Eruption
Patient was taking Hycamtin (View Usage). Patient had the following side effects: anaemia, dermatitis bullous, leukopenia, pancytopenia, skin exfoliation, thrombocytopenia, toxic skin eruption on Aug 02, 2010 from SPAIN Additional patient health information: Male patient , 49 years of age, . Hycamtin dosage: 1mgm2 Per Day. Patient was hospitalized.

6906411-4 | Neoplasm Malignant
Adverse event was reported on Jul 28, 2010 by a Male patient taking Hycamtin (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, After Hycamtin was administered, patient had the following side effects: neoplasm malignant.

6896199-8 | Respiratory Failure
on Jul 26, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with ureteric cancer and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure. Hycamtin dosage: . During the same period patient was treated with ALIMTA (View Alimta Review and Alimta Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.


6817530-5 | Chills, Dyspnoea, Hypersensitivity
on Jul 05, 2010 Male patient from GERMANY , 66 years of age, was treated with Hycamtin (View Usage). Patient had the following side effects: chills, dyspnoea, hypersensitivity. Hycamtin dosage: .

6801417-8 | Abdominal Symptom, Anaemia, Asthenia, Bronchopneumonia, Hypoglycaemia, Inflammation, Purpura, Rash, Rash Macular
Patient was taking Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: abdominal symptom, anaemia, asthenia, bronchopneumonia, hypoglycaemia, inflammation, purpura, rash (What is rash?), rash macular on Jun 18, 2010 from AUSTRIA Additional patient health information: Male patient , 72 years of age, . Hycamtin dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), ZOMETA (View Zometa Review and Zometa Label ), HYDAL (View Hydal Review and Hydal Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMARYL (View Amaryl Review and Amaryl Label ), NEUROMULTIVIT (View Neuromultivit Review and Neuromultivit Label ). Patient was hospitalized.

6778794-X | Rash
Adverse event was reported on Jul 30, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: 3mgm2 Weekly) . Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: rash (What is rash?). During the same period patient was treated with POTASSIUM (View Potassium Review and Potassium Label ), IMDUR (30mgd Per Day) (View Imdur Review and Imdur Label ), REGLAN (View Reglan Review and Reglan Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), PEPCID (View Pepcid Review and Pepcid Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HCTZ (View Hctz Review and Hctz Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ).

6778792-6 | No Adverse Event, Overdose
on Nov 06, 2009 Female patient from UNITED STATES , 29 years of age, was treated with Hycamtin (View Usage). Patient had the following side effects: no adverse event, overdose. Hycamtin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6735930-9 | Neutropenic Sepsis, Pneumonia
on May 14, 2010 Female patient from UNITED KINGDOM , weighting 143.3 lb, was diagnosed with small cell lung cancer recurrent and was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: neutropenic sepsis, pneumonia (What is pneumonia?). Hycamtin dosage: 3mg Per Day.

6724026-8 | Alopecia, Decreased Appetite, Dehydration, Fatigue, Hypotension, Nausea, Pyrexia
Patient was taking Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, decreased appetite, dehydration, fatigue, hypotension, nausea (What is nausea?), pyrexia on May 05, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Hycamtin dosage: . Patient was hospitalized.

6707597-7 | Blood Amylase Increased, Bone Marrow Failure, Bone Marrow Transplant, Diarrhoea, Febrile Neutropenia, Gastrointestinal Haemorrhage, Lipase Increased, Therapeutic Agent Toxicity, Transplant Failure
Adverse event was reported on Apr 19, 2010 by a Male patient taking Hycamtin (View Usage) (Dosage: Intravenous) was diagnosed with acute biphenotypic leukaemia and. Location: UNITED STATES , 15 years of age, Patient had the following side effects: blood amylase increased, bone marrow failure, bone marrow transplant (What is bone marrow transplant?), diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, lipase increased, therapeutic agent toxicity, transplant failure. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 /weekly/ Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), THIOTEPA (15 Mg/m2/intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ). Patient was hospitalized.

6707589-8 | Blood Amylase Increased, Bone Marrow Failure, Bone Marrow Transplant, Hypotension, Leukaemia Recurrent, Lipase Increased, Unevaluable Event
on Apr 19, 2010 Female patient from UNITED STATES , 21 years of age, was diagnosed with acute myeloid leukaemia and was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: blood amylase increased, bone marrow failure, bone marrow transplant (What is bone marrow transplant?), hypotension, leukaemia recurrent, lipase increased, unevaluable event. Hycamtin dosage: Intravenous. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 / Weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ), THIOTEPA (15 Mg/m2/intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45mg/m2) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6707159-1 | Blood Amylase Increased, Blood Culture Positive, Bone Marrow Failure, Colitis, Hepatic Enzyme Increased, Lipase Increased, Lung Infection, Vomiting
on Apr 19, 2010 Female patient from UNITED STATES , child 8 years of age, was diagnosed with t-cell type acute leukaemia and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, blood culture positive, bone marrow failure, colitis, hepatic enzyme increased, lipase increased, lung infection, vomiting. Hycamtin dosage: Intravenous. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 / Weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ), THIOTEPA (15 Mg/m2/ Intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6705846-2 | Blood Culture Positive, Bone Marrow Failure, Cardiac Arrest, Colitis, Disease Complication, Enterococcal Infection, Sepsis
Patient was taking Hycamtin (View Usage). Patient had the following side effects: blood culture positive, bone marrow failure, cardiac arrest (What is cardiac arrest?), colitis, disease complication, enterococcal infection, sepsis (What is sepsis?) on Apr 19, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, was diagnosed with acute myeloid leukaemia and. Hycamtin dosage: Intravenous. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 / Weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), THIOTEPA (15 Mg/m2 /intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ). Patient was hospitalized.

6705845-0 | Blood Culture Positive, Bone Marrow Failure, Bone Marrow Transplant, Convulsion, Hepatic Enzyme Increased, Meningitis
Adverse event was reported on Apr 19, 2010 by a Female patient taking Hycamtin (View Usage) (Dosage: Intravenous) was diagnosed with acute biphenotypic leukaemia and. Location: UNITED STATES , child 7 years of age, After Hycamtin was administered, patient had the following side effects: blood culture positive, bone marrow failure, bone marrow transplant (What is bone marrow transplant?), convulsion, hepatic enzyme increased, meningitis (What is meningitis?). During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 /weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), THIOTEPA (15 Mg/m2 / Intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ). Patient was hospitalized.

6705843-7 | Acute Respiratory Distress Syndrome, Blood Amylase Increased, Blood Culture Positive, Bone Marrow Failure, Colitis, Hypotension, Lipase Increased, Lung Infection
on Apr 19, 2010 Male patient from UNITED STATES , 16 years of age, was diagnosed with b precursor type acute leukaemia and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, blood amylase increased, blood culture positive, bone marrow failure, colitis, hypotension, lipase increased, lung infection. Hycamtin dosage: Intravenous. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 / Weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), THIOTEPA (15 Mg/m2 / Intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ). Patient was hospitalized.

6705834-6 | Blood Culture Positive, Bone Marrow Failure, Colitis, Gastrointestinal Haemorrhage, Hypotension, Lung Infection, Sepsis
on Apr 19, 2010 Female patient from UNITED STATES , child 12 years of age, was diagnosed with acute myeloid leukaemia, acute lymphocytic leukaemia, t-cell type acute leukaemia and was treated with Hycamtin (View Usage). Patient had the following side effects: blood culture positive, bone marrow failure, colitis, gastrointestinal haemorrhage, hypotension, lung infection, sepsis (What is sepsis?). Hycamtin dosage: Intravenous. During the same period patient was treated with VINORELBINE TARTRATE (20 Mg/m2 / Weekly / Intravenous) (View Vinorelbine Tartrate Review and Vinorelbine Tartrate Label ), THIOTEPA (15 Mg/m2 / Intravenous Infusion) (View Thiotepa Review and Thiotepa Label ), DEXAMETHASONE (45 Mg/m2) (View Dexamethasone Review and Dexamethasone Label ), GRANULOCYTE COL.STIM.FACT (View Granulocyte Col.stim.fact Review and Granulocyte Col.stim.fact Label ). Patient was hospitalized.

6578277-6 | Neutropenia
Patient was taking Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: neutropenia on Feb 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, . Hycamtin dosage: 3mg Per Day.

6575982-2 | Haematoma, Rash Erythematous, Rash Vesicular
Adverse event was reported on Jan 14, 2010 by a Female patient taking Hycamtin (View Usage) (Dosage: 3mg Monthly) was diagnosed with ovarian cancer and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: haematoma, rash erythematous, rash vesicular. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), CRESTOR (View Crestor Review and Crestor Label ).

6575595-2 | Tumour Haemorrhage
on Feb 04, 2010 Female patient from UNITED STATES , 55 years of age, was treated with Hycamtin (View Usage). Patient had the following side effects: tumour haemorrhage. Hycamtin dosage: .

6568449-9 |
on Jan 28, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with vulval cancer metastatic and was treated with Hycamtin (View Usage). . Hycamtin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6566828-7 | Dyspnoea
Patient was taking Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea on Jan 27, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with ovarian cancer and. Hycamtin dosage: 1mg See Dosage Text. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), BENADRYL (View Benadryl Review and Benadryl Label ), ATROPINE (View Atropine Review and Atropine Label ), DOCUSATE (View Docusate Review and Docusate Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ). Patient was hospitalized.

6556434-2 | Intestinal Perforation
Adverse event was reported on Jan 07, 2010 by a Male patient taking Hycamtin (View Usage) (Dosage: 4.5mg Per Day) . Location: UNITED KINGDOM , 73 years of age, Patient had the following side effects: intestinal perforation. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6552684-X | Neutropenia
on Jan 20, 2010 Male patient from UNITED KINGDOM , 64 years of age, was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: neutropenia. Hycamtin dosage: 3mg Per Day.

6510152-5 | Anaemia, Confusional State, Haematotoxicity, Leukopenia, Pancytopenia, Pneumonia, Psychotic Disorder
on Dec 18, 2009 Male patient from GERMANY , weighting 167.6 lb, was diagnosed with small cell lung cancer metastatic and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, confusional state, haematotoxicity, leukopenia, pancytopenia, pneumonia (What is pneumonia?), psychotic disorder (What is psychotic disorder?). Hycamtin dosage: 1.25mgm2 Per Day. During the same period patient was treated with FORTECORTIN (View Fortecortin Review and Fortecortin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), SPIRO COMP (View Spiro Comp Review and Spiro Comp Label ). Patient was hospitalized.

6481247-X | Erythema, Oedema Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome, Rash, Skin Exfoliation, Skin Warm
Patient was taking Hycamtin (View Usage). Patient had the following side effects: erythema, oedema peripheral, palmar-plantar erythrodysaesthesia syndrome, rash (What is rash?), skin exfoliation, skin warm on Dec 01, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 184.3 lb, . Hycamtin dosage: 4mg Per Day. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6443123-8 | Dysuria, Failure To Thrive, Pain, Sepsis
Adverse event was reported on Nov 13, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: 4mg Per Day) . Location: UNITED STATES , 58 years of age, After Hycamtin was administered, patient had the following side effects: dysuria, failure to thrive, pain (What is pain?), sepsis (What is sepsis?). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6441501-4 | Abdominal Pain, Bacterial Test Positive, Colitis, Colitis Ischaemic, Diarrhoea, Enterocolitis Infectious, Neutropenia, Pyrexia
on Nov 09, 2009 Male patient from BELGIUM , 50 years of age, weighting 132.3 lb, was diagnosed with lung cancer metastatic and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bacterial test positive, colitis, colitis ischaemic, diarrhoea, enterocolitis infectious, neutropenia, pyrexia. Hycamtin dosage: 2.3mgm2 Per Day. Patient was hospitalized.

6441449-5 | Febrile Neutropenia, Fungal Infection, Mechanical Ventilation, Thrombocytopenia
on Nov 09, 2009 Female patient from UNITED STATES , 58 years of age, weighting 125.9 lb, was treated with Hycamtin (View Usage). Patient had the following side effects: febrile neutropenia, fungal infection (What is fungal infection?), mechanical ventilation, thrombocytopenia. Hycamtin dosage: 2.3mgm2 Per Day. During the same period patient was treated with EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), BROMOCRIPTINE (View Bromocriptine Review and Bromocriptine Label ), AMBIEN (10mg As Required) (View Ambien Review and Ambien Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ). Patient was hospitalized and became disabled.

6430526-0 | Erythema, Oedema Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome, Rash, Skin Exfoliation, Skin Warm
Patient was taking Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: erythema, oedema peripheral, palmar-plantar erythrodysaesthesia syndrome, rash (What is rash?), skin exfoliation, skin warm on Oct 29, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 184.3 lb, . Hycamtin dosage: 4mg Per Day. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6427305-7 | Abdominal Pain, Bacterial Test Positive, Colitis, Colitis Ischaemic, Enterocolitis Infectious, Neutropenia
Adverse event was reported on Oct 27, 2009 by a Male patient taking Hycamtin (View Usage) (Dosage: 2.3mgm2 Per Day) was diagnosed with lung cancer metastatic and. Location: BELGIUM , 50 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bacterial test positive, colitis, colitis ischaemic, enterocolitis infectious, neutropenia. Patient was hospitalized.

6408799-X | Neutropenia
on Oct 15, 2009 Female patient from JAPAN , weighting 125.7 lb, was diagnosed with cervix carcinoma and was treated with Hycamtin (View Usage). Patient had the following side effects: neutropenia. Hycamtin dosage: 1mg Per Day. During the same period patient was treated with CISPLATIN (70mg Per Day) (View Cisplatin Review and Cisplatin Label ), LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), FAMOTIDINE (20mg Per Day) (View Famotidine Review and Famotidine Label ), GRANISETRON HYDROCHLORIDE (3mg Per Day) (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), DEXAMETHASONE SODIUM PHOSPHATE (20mg Per Day) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ). Patient was hospitalized.

6401946-5 | Multi-organ Failure
on Oct 13, 2009 Male patient from UNITED STATES , 61 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: multi-organ failure. Hycamtin dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), DILANTIN (View Dilantin Review and Dilantin Label ). Patient was hospitalized and became disabled.

6370533-X | Dysuria, Pain, Sepsis
Patient was taking Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria, pain (What is pain?), sepsis (What is sepsis?) on Sep 16, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Hycamtin dosage: 4mg Per Day. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6349305-8 | Neutropenia
Adverse event was reported on Sep 02, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: 1mg Per Day) was diagnosed with cervix carcinoma and. Location: JAPAN , weighting 125.7 lb, Patient had the following side effects: neutropenia. During the same period patient was treated with CISPLATIN (70mg Per Day) (View Cisplatin Review and Cisplatin Label ), LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), FAMOTIDINE (20mg Per Day) (View Famotidine Review and Famotidine Label ), GRANISETRON HYDROCHLORIDE (3mg Per Day) (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), DEXAMETHASONE SODIUM PHOSPHATE (20mg Per Day) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ). Patient was hospitalized.

6301272-9 | Asthenia, Cough
on May 04, 2009 Female patient from UNITED STATES , 44 years of age, was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: asthenia, cough. Hycamtin dosage: .

6297997-4 | Bone Marrow Disorder
on Aug 04, 2009 Female patient from JAPAN , 70 years of age, weighting 125.7 lb, was diagnosed with cervix carcinoma and was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow disorder. Hycamtin dosage: .75mgm2 Per Day. During the same period patient was treated with CISPLATIN (50mgm2 Per Day) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6261959-3 | Lung Disorder
Patient was taking Hycamtin (View Usage). Patient had the following side effects: lung disorder on Jun 30, 2009 from JAPAN Additional patient health information: Male patient , 63 years of age, . Hycamtin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ).

6258722-6 | Cough, Dyspnoea, Hypoxia, Respiratory Depth Decreased
Adverse event was reported on Jun 30, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 180.8 lb, After Hycamtin was administered, patient had the following side effects: cough, dyspnoea, hypoxia, respiratory depth decreased.

6240150-0 | Interstitial Lung Disease
on Apr 16, 2009 Female patient from UNITED STATES , 72 years of age, was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Hycamtin dosage: 4mg Weekly. Patient was hospitalized.

6240149-4 | Tinnitus
on Feb 17, 2009 Female patient from UNITED STATES , 73 years of age, was treated with Hycamtin (View Usage). Patient had the following side effects: tinnitus (What is tinnitus?). Hycamtin dosage: 2.2mg Per Day. During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), AVALIDE (View Avalide Review and Avalide Label ), CALCIUM (View Calcium Review and Calcium Label ), COLACE (View Colace Review and Colace Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ).

6234964-0 | Aggression, Agitation, Altered State Of Consciousness, Brain Oedema, Cerebral Disorder, Delirium, Disorientation, Disturbance In Attention, Fatigue
Patient was taking Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: aggression, agitation, altered state of consciousness, brain oedema, cerebral disorder, delirium, disorientation, disturbance in attention, fatigue on Jun 15, 2009 from GERMANY Additional patient health information: Female patient , weighting 180.8 lb, was diagnosed with non-small cell lung cancer and. Hycamtin dosage: . During the same period patient was treated with FORTECORTIN (View Fortecortin Review and Fortecortin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSID (View Etoposid Review and Etoposid Label ). Patient was hospitalized.

6208869-5 | Cough, Dyspnoea, Hypoxia, Respiratory Depth Decreased
Adverse event was reported on May 20, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, hypoxia, respiratory depth decreased.

6184054-0 | Dry Mouth, Dysgeusia, Fatigue, Somnolence
on Mar 25, 2009 Female patient from UNITED STATES , 68 years of age, was treated with Hycamtin (View Usage). Patient had the following side effects: dry mouth, dysgeusia, fatigue, somnolence. Hycamtin dosage: .

6184053-9 | Diarrhoea, Nausea
on Feb 13, 2009 Female patient from UNITED STATES , 69 years of age, was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: diarrhoea, nausea (What is nausea?). Hycamtin dosage: 3mgd Per Day.

6179401-X | Bacteraemia, Disease Progression, No Therapeutic Response, Non-small Cell Lung Cancer Metastatic, Respiratory Distress, Stridor
Patient was taking Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, disease progression, no therapeutic response, non-small cell lung cancer metastatic, respiratory distress, stridor on Apr 27, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, . Hycamtin dosage: 2.4mg Variable Dose. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROVENTIL (View Proventil Review and Proventil Label ), XANAX (View Xanax Review and Xanax Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), BENADRYL (View Benadryl Review and Benadryl Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6158698-6 | Disease Progression, Dyspnoea
Adverse event was reported on Apr 10, 2009 by a Female patient taking Hycamtin (View Usage) (Dosage: 4mgm2 Weekly) was diagnosed with metastases to ovary and. Location: UNITED STATES , 48 years of age, weighting 216.5 lb, Patient had the following side effects: disease progression, dyspnoea. During the same period patient was treated with BRONCHODILATOR (View Bronchodilator Review and Bronchodilator Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6151736-6 | Respiratory Distress
on Apr 03, 2009 Female patient from UNITED STATES , 55 years of age, was treated with Hycamtin (View Usage). After Hycamtin was administered, patient had the following side effects: respiratory distress. Hycamtin dosage: 2.4mg Variable Dose. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROVENTIL (View Proventil Review and Proventil Label ), XANAX (View Xanax Review and Xanax Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), BENADRYL (View Benadryl Review and Benadryl Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6144665-5 | Interstitial Lung Disease
on Mar 31, 2009 Male patient from JAPAN , 60 years of age, was treated with Hycamtin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Hycamtin dosage: .

6126183-3 | Computerised Tomogram Abnormal, Cough, Dyspnoea
Patient was taking Hycamtin (View Usage). Patient had the following side effects: computerised tomogram abnormal, cough, dyspnoea on Mar 11, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, weighting 180.8 lb, . Hycamtin dosage: .